prostatecancer.news valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 

                

                
Meta Tags

                

                    

                        Title
                        Prostate Cancer News, Reviews &                        
                    

                    

                        Description
                                                        Prostate Cancer News, Reviews & Views Saturday, May 6, 2023 Xtandi (enzalutamide) +ADT slows metastases in recurrent men It is always difficult for a recu                                                    
                    

                    

                        Keywords
                                                        N/A
                                                    
                    

                

                
Server Information

                

                    

                        WebSite
                        prostatecancer faviconprostatecancer.news                            
                        
                    

                    

                        Host IP
                        216.239.32.21                        
                    

                    

                        Location
                        United States                        
                    

                

                
Related Websites

                

                    

                        Site
                        Rank
                    

                

                
More to Explore

                


                     
                

            

            

                
prostatecancer.news Valuation

                

                    

                        
                            

                                
US$801,326                                

                                

                                
                                

                                    Last updated: 2023-05-18 09:22:05                                    
                                

                            

                            
prostatecancer.news has Semrush global rank of 13,208,494. prostatecancer.news has an estimated worth of US$ 801,326, based on its estimated Ads revenue. prostatecancer.news receives approximately 92,461 unique visitors each day. Its web server is located in United States, with IP address 216.239.32.21. According to SiteAdvisor, prostatecancer.news is safe to visit.
                            

                        		
                    

                

                
Traffic & Worth Estimates

                

                    

                        Purchase/Sale Value
                        US$801,326                            
                    

                    

                        Daily Ads Revenue
                        US$740                            
                    

                    

                        Monthly Ads Revenue
                        US$22,191                            
                    

                    

                        Yearly Ads Revenue
                        US$266,287                            
                    

                    

                        Daily Unique Visitors
                        6,165
                        
                    

                    

                        
                            Note: All traffic and earnings values are estimates.
                        
                    

                

                

                    
                

                                    
                
                
DNS Records

                

                    

                        Host
                        Type
                        TTL
                        Data
                    

                                        

                        prostatecancer.news.                        
                        A
                        
                        3600                        
                        IP: 216.239.32.21                        
                    

                                        

                        prostatecancer.news.                        
                        A
                        
                        3600                        
                        IP: 216.239.38.21                        
                    

                                        

                        prostatecancer.news.                        
                        A
                        
                        3600                        
                        IP: 216.239.36.21                        
                    

                                        

                        prostatecancer.news.                        
                        A
                        
                        3600                        
                        IP: 216.239.34.21                        
                    

                                                            

                        prostatecancer.news.                        
                        AAAA
                        
                        3600                        
                        IPV6: 2001:4860:4802:36::15                        
                    

                                        

                        prostatecancer.news.                        
                        AAAA
                        
                        3600                        
                        IPV6: 2001:4860:4802:38::15                        
                    

                                        

                        prostatecancer.news.                        
                        AAAA
                        
                        3600                        
                        IPV6: 2001:4860:4802:34::15                        
                    

                                        

                        prostatecancer.news.                        
                        AAAA
                        
                        3600                        
                        IPV6: 2001:4860:4802:32::15                        
                    

                                                            

                        prostatecancer.news.                        
                        NS
                        
                        21600                        
                        NS Record: ns-cloud-e2.googledomains.com.                        
                    

                                        

                        prostatecancer.news.                        
                        NS
                        
                        21600                        
                        NS Record: ns-cloud-e3.googledomains.com.                        
                    

                                        

                        prostatecancer.news.                        
                        NS
                        
                        21600                        
                        NS Record: ns-cloud-e4.googledomains.com.                        
                    

                                        

                        prostatecancer.news.                        
                        NS
                        
                        21600                        
                        NS Record: ns-cloud-e1.googledomains.com.                        
                    

                                                            
                

                
                                
HtmlToTextCheckTime:2023-05-18 09:22:05

                

                    

                        
                            Prostate Cancer News, Reviews & Views Saturday, May 6, 2023 Xtandi (enzalutamide) +ADT slows metastases in recurrent men It is always difficult for a recurrent patient (rising PSA after prostatectomy, radiation, or both) with no metastases to decide when to start salvage hormone therapy and, if so, which hormone therapy. That is the question that the EMBARK randomized clinical trial (RCT) sought to answer. We have recently seen that the PRESTO trial proved that a one-year course of ADT+ apalutamide (Erleada) significantly delayed biochemical progression compared to ADT alone. EMBARK Protocol This was a huge trial with 1,068 patients treated at 256 centers around the world. To qualify, patients had to have: Biochemical progression after attempted curative treatment with prostatectomy (RP), radiation (RT), or both (SRT). PSA≥ 1 ng/ml if RP; ≥ 2 ng/ml above nadir if RT PSA doubling time (PSADT) ≤ 9 months No metastases on conventional imaging Patients were randomized to one of three                            
                        
                    

                

                
                
                                
HTTP Headers

                

                    

                        
                            
HTTP/1.1 301 Moved Permanently
Location: http://www.prostatecancer.news/
Date: Fri, 10 Jun 2022 04:20:54 GMT
Content-Type: text/html; charset=UTF-8
Server: ghs
Content-Length: 228
X-XSS-Protection: 0
X-Frame-Options: SAMEORIGIN

HTTP/1.1 301 Moved Permanently
Location: https://www.prostatecancer.news/
Content-Type: text/html; charset=UTF-8
Date: Fri, 10 Jun 2022 04:20:54 GMT
Expires: Fri, 10 Jun 2022 04:20:54 GMT
Cache-Control: private, max-age=0
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Content-Security-Policy: frame-ancestors 'self'
X-XSS-Protection: 1; mode=block
Server: GSE
Transfer-Encoding: chunked
Accept-Ranges: none
Vary: Accept-Encoding

HTTP/2 200 
content-type: text/html; charset=UTF-8
expires: Fri, 10 Jun 2022 04:20:55 GMT
date: Fri, 10 Jun 2022 04:20:55 GMT
cache-control: private, max-age=0
last-modified: Wed, 08 Jun 2022 22:08:03 GMT
etag: W/"c5d119629e621d5069e16d9c5ebcebbea7c17314a58ad86f227e9221db1c3cb2"
x-content-type-options: nosniff
x-xss-protection: 1; mode=block
content-length: 0
server: GSE

                        		
                    

                

                
                                
prostatecancer.news Whois Information

                

                    

                        
                            
Domain Name: prostatecancer.news
Registry Domain ID: 43d55f81b9034dec8fd2faf7ed9e7187-DONUTS
Registrar WHOIS Server: whois.donuts.co
Registrar URL: http://domains.google.com
Updated Date: 2022-05-29T20:41:39Z
Creation Date: 2020-05-29T20:41:27Z
Registry Expiry Date: 2023-05-29T20:41:27Z
Registrar: Google Inc.
Registrar IANA ID: 895
Registrar Abuse Contact Email: registrar-abuse@google.com
Registrar Abuse Contact Phone: +1.8772376466
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: autoRenewPeriod https://icann.org/epp#autoRenewPeriod
Registrant Organization: Contact Privacy Inc. Customer 7151571251
Registrant State/Province: ON
Registrant Country: CA
Name Server: ns-cloud-e1.googledomains.com
Name Server: ns-cloud-e2.googledomains.com
Name Server: ns-cloud-e3.googledomains.com
Name Server: ns-cloud-e4.googledomains.com
DNSSEC: signedDelegation
>>> Last update of WHOIS database: 2022-06-03T11:54:49Z <<<

                        		
                    

                

                            

        

        

        

            
        

    

    

        
Copyright © 2022 WebZZ.US 0.0220